Patents Assigned to New Medical Enzymes AG
  • Glutadon
    Patent number: 8465736
    Abstract: The present invention relates to a pharmaceutical combination product for cancer therapy. The combination product comprises the two active ingredients glutaminase and 6-diazo-5-oxo-L-norleucine (DON). The invention further relates to the use of such a combination product for the treatment of cancers.
    Type: Grant
    Filed: May 10, 2007
    Date of Patent: June 18, 2013
    Assignee: New Medical Enzymes AG
    Inventors: Michael Bausch, Wetzler Rainer, Christian Muller